HMGN Financials 07/16/2014 14:59:36 Hemagen Diagn

HMGN Financials 07/16/2014 14:59:36
Hemagen Diagnostics, Inc.
Period Ending Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue 4,042 5,141 5,220
Cost of Revenue 2,429 3,180 2,864
Gross Profit 1,613 1,961 2,356
Operating Expenses
Research and Development 45 5 25
Sales, General and Admin. 2,007 2,429 2,095
Non-Recurring Items - - -
Other - - -
Operating Income (438) (473) 236
Income From Continuing Operations
Add'l Income/Expense Items - 3 30
Earnings Before Interest and Tax (438) (470) (67)
Interest Expense 469 407 -
Earnings Before Tax (907) (876) (67)
Income Tax - 4 90
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (907) (880) (156)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (907) (880) (156)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (907) (880) (156)